Evidence map›Paper›PMID 38719028›Full record

ReviewMolecular and biochemical parasitology2024

TKL family kinases in human apicomplexan pathogens.

Dima Hajj Ali, Rajshekhar Y Gaji

Abstract readReview
In one paragraph

Review in Molecular and biochemical parasitology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dima Hajj AliDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA.
Rajshekhar Y GajiDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA. Electronic address: rajgaji@vt.edu.

Funding

Exploring the function of a novel tyrosine kinase like (TKL) protein in Toxoplasma endodyogenyR21AI162606 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI GAJI, RAJSHEKHAR · 2022 to 2023
$440k
NIAID NIH HHS R21 AI162606
6 · The paper itself

Abstract

Apicomplexan parasites are the primary causative agents of many human diseases, including malaria, toxoplasmosis, and cryptosporidiosis. These opportunistic pathogens undergo complex life cycles with multiple developmental stages, wherein many key steps are regulated by phosphorylation mechanisms. The genomes of apicomplexan pathogens contain protein kinases from different groups including tyrosine kinase-like (TKL) family proteins. Although information on the role of TKL kinases in apicomplexans is quite limited, recent studies have revealed the important role of this family of proteins in apicomplexan biology. TKL kinases in these protozoan pathogens show unique organization with many novel domains thus making them attractive candidates for drug development. In this mini review, we summarize the current understanding of the role of TKL kinases in human apicomplexan pathogens' (Toxoplasma gondii, Plasmodium falciparum and Cryptosporidium parvum) biology and pathogenesis.

Indexed as

ApicomplexaCryptosporidium parvumPlasmodium falciparumProtozoan ProteinsToxoplasmaHumansPhosphorylationProtein-Tyrosine KinasesProtein-Tyrosine KinasesProtozoan ProteinsApicomplexaCryptosporidium parvumPhosphorylationPlasmodium falciparumProtein kinaseToxoplasma gondii

Identifiers

PMID38719028
PMCPMC11182715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.